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Background
Recent evidence suggests that leukocyte-associated immu-
noglobulin-like receptor-1 (LAIR-1) may play an impor-
tant role in down-regulating immune activities upon
collagen binding [1], and its defective expression or dys-
function is clinically associated with some autoimmune
diseases [2-5], cancer [6-8] and viral infection [9-12]. The
human genome encodes the counterpart to LAIR-1, solu-
ble protein LAIR-2 [13], which also binds collagen and
can interfere with LAIR-1/collagen interactions [14]. How-
ever, LAIR-2 has no homologue in mouse or rat [13]. To
clarify the extrapolative credibility of a murine model to
human disease, we compared LAIR-1 genetic pathways in
internal organs of the two species.
Materials and methods
Data source
We used the GeneNetwork software developed by the
University of Tennessee, and six eligible datasets of normal
liver, lung, and brain tissue from the linked database [15].
Statistical analysis
The top genes shared by mouse and human on the basis
of Pearson correlation, were picked for plotting network
graphs in GeneNetwork. An r absolute value >0.50 was
considered to indicate connection line threshold.
Results
Significant variation in LAIR-1 genetic pathways was
found in mouse vs human internal organs
The top 50 mouse genes by LAIR-1’s Pearson correlation
were employed to search for the same genes in corre-
sponding human tissue throughout relevant databases.
There were 33 common genes found in liver, 32 in lung,
and 31 in brain. The network node of LAIR-1 has a more
robust connection for mouse than for human, and no
common genes except for LAIR-1 were shared by liver,
lung and brain in mice or humans. These observations can
be confirmed in liver with the common genes of the top
100 human and top 100 mouse LAIR-1 relevant genes.
Genetic interaction of human LAIR-1 with LAIR-2 in vivo
rarely occurred
The interaction of LAIR-2 with LAIR-1 only occurred in
the top 200 genes for lung tissue with a positive coeffi-
cient of 0.426, and in the top 300 genes for brain tissue
with a negative coefficient of -0.242, but not for liver tis-
sue, according to Pearson correlation distance and
intensity.
Conclusions
LAIR-1 genetic pathways have noteworthy species differ-
ence and tissue specificity, which may cause overestima-
tion if using mouse experimental data to evaluate human
conditions. Moreover, human LAIR-1 and LAIR-2 actually
get the rare opportunity to interact in vivo, implying that
species difference in regard to LAIR-1 genetic pathways
could not be primarily attributed to the existence of
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